-
公开(公告)号:US11938016B2
公开(公告)日:2024-03-26
申请号:US16943883
申请日:2020-07-30
发明人: Nicholas Lachlan Opie , Thomas James Oxley , Gil Simon Rind , Stephen Michael Ronayne , Sam Emmanuel John
IPC分类号: A61B5/00 , A61B5/24 , A61B5/283 , A61B5/291 , A61F2/06 , A61F2/90 , A61N1/05 , A61B5/0215 , A61F2/88
CPC分类号: A61F2/06 , A61B5/24 , A61B5/283 , A61B5/291 , A61B5/4052 , A61B5/4064 , A61B5/6862 , A61F2/90 , A61N1/0529 , A61B5/0215 , A61B5/4836 , A61B5/7207 , A61B2505/09 , A61F2/88 , A61F2230/0067 , A61F2250/0001
摘要: Devices, methods and systems for transmitting signals through a device located in a blood vessel of an animal, for stimulating and/or sensing activity of media proximal to the device, wherein the media includes tissue and/or fluid.
-
公开(公告)号:US20230272048A1
公开(公告)日:2023-08-31
申请号:US18007859
申请日:2021-06-10
发明人: Damian PURCELL , Behnaz HEYDARCHI
CPC分类号: C07K16/081 , C12N15/63 , A61P31/18 , C07K2317/76 , C07K2317/565 , C07K2317/567 , C07K2317/92
摘要: The invention relates to antigen binding sites, antibodies and fragments thereof, as well as compositions, kits and uses thereof for the treatment, attenuation and/or prevention of human immunodeficiency virus type 1 (HIV-1).
-
公开(公告)号:US20230193389A1
公开(公告)日:2023-06-22
申请号:US17967277
申请日:2022-10-17
申请人: ITEK VENTURES PTY LTD , The University of Melbourne , Central Adelaide Local Health Network Incorporated
发明人: Sarah Elizabeth Heron , Leanne Michelle Dibbens , Samuel Frank Berkovic , Ingrid Eileen Scheffer , John Charles Mulley
IPC分类号: C12Q1/6883 , C07K14/705 , C07K14/47 , C07K16/18 , G01N27/447
CPC分类号: C12Q1/6883 , C07K14/705 , C07K14/47 , C07K16/18 , G01N27/447 , C12Q2600/156 , C12Q2600/118 , C12Q2600/136
摘要: The present invention related to the proline rich transmembrane protein 2 (PRRT2) gene, and the identification of mutations and variations in PRRT2 that give rise to seizure and movement disorders. Accordingly, the present invention provides methods for the diagnosis or prognosis of such disorders by identifying alterations in the PRRT2 gene. Identification of alterations in the PRRT2 gene also enables the identification of subjects with an increased likelihood of having an offspring predisposed to such disorders. The present invention also provides an isolated nucleic acid molecule comprising an alteration in the PRRT2 gene, wherein said alteration produces a seizure and/or movement disorder phenotype. Also provided is an isolated PRRT2 polypeptide that comprises an alteration which produces a seizure and/or movement disorder phenotype. Furthermore, the present invention provides kit for diagnosing or prognosing a seizure and/or movement disorder in a subject, or for identifying a subject with an increased likelihood of having an offspring predisposed to a seizure and/or movement disorder, wherein the kit includes one or more components for testing for the presence of an alteration in the PRRT2 gene in the subject.
-
公开(公告)号:US20230146291A1
公开(公告)日:2023-05-11
申请号:US18087672
申请日:2022-12-22
发明人: Alastair Stewart , Christine Keenan , Trudi Harris
IPC分类号: A61K31/519 , A61K45/06 , A61K31/4439 , A61K31/444 , A61K31/506 , A61K31/58 , A61K31/573 , A61P35/00 , C07D403/04 , C07D405/14 , C07D413/14 , C07D487/04
CPC分类号: A61K31/519 , A61K31/58 , A61K31/444 , A61K31/506 , A61K31/573 , A61K31/4439 , A61K45/06 , A61P35/00 , C07D403/04 , C07D405/14 , C07D413/14 , C07D487/04
摘要: The present invention relates to compositions, methods and kits for the treatment of respiratory disease. In particular, the compositions, methods and kits are particularly useful, but not limited to, the treatment or prevention of exacerbations of asthma and chronic obstructive pulmonary disease. The present invention provides a method of treating or preventing a respiratory disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an inhibitor of casein kinase 1, thereby treating or preventing a respiratory disease in a subject. The present invention also provides a method of treating or preventing a respiratory disease in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an inhibitor of ALK5, thereby treating or preventing a respiratory disease in a subject, wherein the inhibitor is administered directly to the airway and/or lungs. The present invention also provides a method of treating or preventing a condition of the airway or lung involving fibrosis in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an inhibitor of casein kinase 1 or an inhibitor of ALK5, thereby treating or preventing a condition of the airway or lung involving fibrosis in a subject.
-
公开(公告)号:US11517617B2
公开(公告)日:2022-12-06
申请号:US16645067
申请日:2018-09-07
IPC分类号: A61K39/145 , C07K7/06 , C07K7/08
摘要: The present invention provides novel methods and compositions for use in preventing infection with at least one type of influenza virus, including the use of peptides or compositions comprising a peptide comprising, consisting or consisting essentially of an amino acid sequence selected from the group of sequences as shown in SEQ ID Nos: 1 to 53, or functional derivatives or homologues thereof.
-
公开(公告)号:US20220380343A1
公开(公告)日:2022-12-01
申请号:US17690855
申请日:2022-03-09
发明人: Spencer Williams , Sayali Shah , Zalihe Hakki , Alastair Stewart
IPC分类号: C07D401/14 , A61P11/06 , C07D403/04
摘要: The present invention relates to new compounds that are useful in the prevention or treatment of respiratory diseases, such as asthma, to the preparation of the compounds, and to compositions including the compounds. The present invention also relates to the use of the compounds, as well as compositions including the compounds, in treating or preventing respiratory diseases.
-
公开(公告)号:US11504305B2
公开(公告)日:2022-11-22
申请号:US15609564
申请日:2017-05-31
摘要: The present invention relates to compositions and methods for mineralizing a dental surface or subsurface including providing a composition including stabilized ACP and a source of fluoride ions.
-
公开(公告)号:US20220362337A1
公开(公告)日:2022-11-17
申请号:US17824654
申请日:2022-05-25
发明人: Andrew Wise , Robert K. Shepherd , Frank Caruso
IPC分类号: A61K38/18 , A61P27/16 , A61K9/00 , A61K9/16 , A61K31/573 , A61K38/20 , A61K9/06 , A61K9/51 , A61K47/36
摘要: The present invention relates to methods of treating an auditory disorder. In particular, the present invention relates to treating an auditory disorder using supraparticles comprising a therapeutic payload.
-
公开(公告)号:US20220340863A1
公开(公告)日:2022-10-27
申请号:US17642391
申请日:2020-09-11
摘要: The present disclosure relates to hydrogels composition comprising protist cells. In particular, the present disclosure relates to hydrogel compositions which may be used to encapsulate or suspend ciliated protist cells, and methods of preparing the same. The present disclosure further relates to methods of infecting molluscs with a ciliated protist cell, and methods and compositions for stabilising ciliated protist cells.
-
公开(公告)号:US20220331129A1
公开(公告)日:2022-10-20
申请号:US17810189
申请日:2022-06-30
摘要: Devices, methods and systems for transmitting signals through a device located in a blood vessel of an animal for stimulating and/or sensing activity of media proximal to the devices. The media can include tissue and/or fluid. A method of controlling an apparatus in communication with a brain machine interface. The method can include measuring a first neural activity in a first neural area and measuring a second neural activity in a second neural area. The first neural activity can be associated with a first intent. The method can include creating and delivering, via the processor, one or more first control signals to the apparatus upon comparing the second neural activity with the first neural activity, and confirming, based on this comparison, that the second neural activity is associated with the first intent.
-
-
-
-
-
-
-
-
-